Angiotensin receptor blockers for heart failure
- PMID: 25267889
- PMCID: PMC4176658
- DOI: 10.1002/14651858.CD003040
Angiotensin receptor blockers for heart failure
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the efficacy of ARBs on the survival of patients with heart failure when compared to placebo or ACEIs.To determine the efficacy of ARBs on hospitalization rates in patients with heart failure when compared to placebo or ACEIs.
References
-
- Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol. 1999;10(Suppl 11):S30–S39. [MEDLINE: 87] - PubMed
-
- Brunner-La Rocca HP, Vaddadi G, Esler MD. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol. 1999;33(5):1163–1173. [MEDLINE: 81] - PubMed
-
- Clarke M, Oxman AD. Review Manager (RevMan). Version 4.0. The Cochrane Collaboration; Oxford, England: 1999. Cochrane Reviewers’ Handbook 4.0. [MEDLINE: 90200]
-
- Davie AP, Dargie HJ, McMurray JJ. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure. Circulation. 1999 Jul 20;100(3):268–273. [MEDLINE: 95] - PubMed
-
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. [MEDLINE: 90116] - PubMed
LinkOut - more resources
Full Text Sources